Hilton Capital Management LLC acquired a new stake in 22nd Century Group Inc (NYSEAMERICAN:XXII) during the fourth quarter, HoldingsChannel reports. The fund acquired 75,000 shares of the biotechnology company’s stock, valued at approximately $210,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Steward Partners Investment Advisory LLC acquired a new position in 22nd Century Group in the 3rd quarter valued at $100,000. Wells Fargo & Company MN grew its holdings in shares of 22nd Century Group by 1,422.2% during the 3rd quarter. Wells Fargo & Company MN now owns 68,500 shares of the biotechnology company’s stock worth $190,000 after purchasing an additional 64,000 shares in the last quarter. Monashee Investment Management LLC acquired a new stake in shares of 22nd Century Group during the 4th quarter worth $195,000. Advisor Group Inc. grew its holdings in shares of 22nd Century Group by 49.3% during the 3rd quarter. Advisor Group Inc. now owns 73,775 shares of the biotechnology company’s stock worth $204,000 after purchasing an additional 24,375 shares in the last quarter. Finally, Creative Planning grew its holdings in shares of 22nd Century Group by 38.7% during the 4th quarter. Creative Planning now owns 73,915 shares of the biotechnology company’s stock worth $207,000 after purchasing an additional 20,628 shares in the last quarter.

How to Become a New Pot Stock Millionaire

Several research firms have recently issued reports on XXII. Chardan Capital reissued a “buy” rating and set a $11.50 target price on shares of 22nd Century Group in a report on Friday, January 26th. Zacks Investment Research lowered 22nd Century Group from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th.

Shares of 22nd Century Group stock opened at $2.48 on Thursday. The stock has a market capitalization of $316.82, a price-to-earnings ratio of -19.08 and a beta of 3.25. 22nd Century Group Inc has a 1-year low of $0.89 and a 1-year high of $4.44.

ILLEGAL ACTIVITY WARNING: “Hilton Capital Management LLC Takes Position in 22nd Century Group Inc (XXII)” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/hilton-capital-management-llc-takes-position-in-22nd-century-group-inc-xxii/1957807.html.

About 22nd Century Group

22nd Century Group, Inc is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.

Want to see what other hedge funds are holding XXII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 22nd Century Group Inc (NYSEAMERICAN:XXII).

Institutional Ownership by Quarter for 22nd Century Group (NYSEAMERICAN:XXII)

Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.